Zoetis (ZTS) Dividends Paid - Common (2012 - 2026)
Zoetis' (ZTS) quarterly Dividends Paid - Common came in at $224.0 million in Q1 2026, little changed year-on-year from $224.0 million in Q1 2025, and up 1.82% on a QoQ basis from $220.0 million in Q4 2025.
Zoetis (ZTS) Dividends Paid - Common (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has 15 years of Dividends Paid - Common data on file, last reported at $224.0 million in Q1 2026.
- On a quarterly basis, Dividends Paid - Common changed 0.0% year-over-year to $224.0 million in Q1 2026; TTM through Mar 2026 was $889.0 million, a 9.48% increase from a year earlier, with the FY2025 full-year figure at $889.0 million, up 13.1% from the prior year.
- Dividends Paid - Common for Q1 2026 stood at $224.0 million, up from $220.0 million in the prior quarter.
- Over the last five years, Dividends Paid - Common for ZTS reached as high as $224.0 million in Q1 2025 and fell as low as $151.0 million in Q4 2022.
- Historically, Dividends Paid - Common has averaged $188.4 million across 5 years, with a median of $194.0 million in 2024.
- Across the five-year window, Dividends Paid - Common climbed 29.41% in 2022 and changed 0.0% in 2026, its largest moves.
- Year by year, Dividends Paid - Common stood at $151.0 million in 2022, then grew by 13.91% to $172.0 million in 2023, then advanced by 12.79% to $194.0 million in 2024, then increased by 13.4% to $220.0 million in 2025, then gained by 1.82% to $224.0 million in 2026.
- Per Business Quant data, the three most recent Dividends Paid - Common figures were $224.0 million in Q1 2026, $220.0 million in Q4 2025, and $222.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 224.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.92 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 139.60 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 224.00 Mn |
| Mar 31, 2026 | 224.00 Mn |
| Dec 31, 2025 | 220.00 Mn |
| Dec 31, 2025 | 220.00 Mn |
| Sep 30, 2025 | 222.00 Mn |
| Sep 30, 2025 | 222.00 Mn |
| Jun 30, 2025 | 223.00 Mn |
| Jun 30, 2025 | 223.00 Mn |
| Mar 31, 2025 | 224.00 Mn |
| Mar 31, 2025 | 224.00 Mn |
| Dec 31, 2024 | 194.00 Mn |
| Dec 31, 2024 | 194.00 Mn |
| Sep 30, 2024 | 197.00 Mn |
| Sep 30, 2024 | 197.00 Mn |
| Jun 30, 2024 | 197.00 Mn |
| Jun 30, 2024 | 197.00 Mn |
| Mar 31, 2024 | 198.00 Mn |
| Mar 31, 2024 | 198.00 Mn |
| Dec 31, 2023 | 172.00 Mn |
| Dec 31, 2023 | 172.00 Mn |